Non-steroidal Anti-inflammatory Drugs (NSAID) Market Report

Global and Region Non-steroidal Anti-inflammatory Drugs (NSAID) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：228
  • REPORT CODE：GMM954483
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Non-steroidal Anti-inflammatory Drugs (NSAID) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)market, defines the market attractiveness level of Non-steroidal Anti-inflammatory Drugs (NSAID) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Non-steroidal Anti-inflammatory Drugs (NSAID) industry, describes the types of Non-steroidal Anti-inflammatory Drugs (NSAID) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Non-steroidal Anti-inflammatory Drugs (NSAID) market and the development prospects and opportunities of Non-steroidal Anti-inflammatory Drugs (NSAID) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Non-steroidal Anti-inflammatory Drugs (NSAID) market in Chapter 13.

    By Player:

    • Zoetis

    • Elanco

    • Boehringer Ingelheim

    • St Joseph

    • Ecotrin

    • Merck Animal Health

    • Merial

    • Generic

    • Bayer

    By Type:

    • Salicylates

    • Propionic acid derivatives

    • Acetic acid derivatives

    • Enolic acid (Oxicam) derivatives

    • Anthranilic acid derivatives (Fenamates)

    • Selective COX-2 inhibitors (Coxibs)

    • Sulfonanilides

    By End-User:

    • Human

    • Animals

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Non-steroidal Anti-inflammatory Drugs (NSAID) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis and Outlook to 2022

    • 7.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption (2017-2022)

    • 7.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption (2017-2022)

    • 7.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption (2017-2022)

    • 7.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption (2017-2022)

    • 7.5 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption (2017-2022)

    • 7.6 India Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption (2017-2022)

    • 7.7 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption (2017-2022)

    8 Region and Country-wise Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis and Outlook to 2028

    • 8.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast (2022-2028)

    • 8.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast (2022-2028)

    • 8.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast (2022-2028)

    • 8.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast (2022-2028)

    • 8.5 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast (2022-2028)

    • 8.6 India Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast (2022-2028)

    • 8.7 South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast (2022-2028)

    9 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Outlook by Types and Applications to 2022

    • 9.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Salicylates Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Propionic acid derivatives Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Acetic acid derivatives Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Enolic acid (Oxicam) derivatives Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Anthranilic acid derivatives (Fenamates) Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Selective COX-2 inhibitors (Coxibs) Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Sulfonanilides Consumption and Growth Rate (2017-2022)

    • 9.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Human Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Animals Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Outlook by Types and Applications to 2028

    • 10.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Salicylates Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Propionic acid derivatives Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Acetic acid derivatives Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Enolic acid (Oxicam) derivatives Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Anthranilic acid derivatives (Fenamates) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Selective COX-2 inhibitors (Coxibs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Sulfonanilides Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Human Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Animals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Analysis

    • 14.1 Zoetis

      • 14.1.1 Zoetis Company Details

      • 14.1.2 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • 14.2 Elanco

      • 14.2.1 Elanco Company Details

      • 14.2.2 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • 14.3 Boehringer Ingelheim

      • 14.3.1 Boehringer Ingelheim Company Details

      • 14.3.2 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • 14.4 St Joseph

      • 14.4.1 St Joseph Company Details

      • 14.4.2 St Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 St Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • 14.5 Ecotrin

      • 14.5.1 Ecotrin Company Details

      • 14.5.2 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • 14.6 Merck Animal Health

      • 14.6.1 Merck Animal Health Company Details

      • 14.6.2 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • 14.7 Merial

      • 14.7.1 Merial Company Details

      • 14.7.2 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • 14.8 Generic

      • 14.8.1 Generic Company Details

      • 14.8.2 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • 14.9 Bayer

      • 14.9.1 Bayer Company Details

      • 14.9.2 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Non-steroidal Anti-inflammatory Drugs (NSAID)

    • Figure Non-steroidal Anti-inflammatory Drugs (NSAID) Picture

    • Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption by Country (2017-2022)

    • Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption and Growth Rate (2017-2022)

    • Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption and Growth Rate (2017-2022)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption and Growth Rate (2017-2022)

    • Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption and Growth Rate (2017-2022)

    • Figure India Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption and Growth Rate (2017-2022)

    • Figure Global Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast by Country (2022-2028)

    • Figure United States Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Salicylates Consumption and Growth Rate (2017-2022)

    • Figure Global Propionic acid derivatives Consumption and Growth Rate (2017-2022)

    • Figure Global Acetic acid derivatives Consumption and Growth Rate (2017-2022)

    • Figure Global Enolic acid (Oxicam) derivatives Consumption and Growth Rate (2017-2022)

    • Figure Global Anthranilic acid derivatives (Fenamates) Consumption and Growth Rate (2017-2022)

    • Figure Global Selective COX-2 inhibitors (Coxibs) Consumption and Growth Rate (2017-2022)

    • Figure Global Sulfonanilides Consumption and Growth Rate (2017-2022)

    • Figure Global Human Consumption and Growth Rate (2017-2022)

    • Figure Global Animals Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Salicylates Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Propionic acid derivatives Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acetic acid derivatives Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Enolic acid (Oxicam) derivatives Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anthranilic acid derivatives (Fenamates) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Selective COX-2 inhibitors (Coxibs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sulfonanilides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Human Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Animals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Non-steroidal Anti-inflammatory Drugs (NSAID) Export by Region (Top 5 Countries) (2017-2028)

    • Table Zoetis (Foundation Year, Company Profile and etc.)

    • Table Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • Table Elanco (Foundation Year, Company Profile and etc.)

    • Table Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • Table St Joseph (Foundation Year, Company Profile and etc.)

    • Table St Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

    • Table St Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • Table Ecotrin (Foundation Year, Company Profile and etc.)

    • Table Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • Table Merck Animal Health (Foundation Year, Company Profile and etc.)

    • Table Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • Table Merial (Foundation Year, Company Profile and etc.)

    • Table Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • Table Generic (Foundation Year, Company Profile and etc.)

    • Table Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US